Topics

Deal Watch: Castle Creek Likes Partner Fibrocell Enough To Buy It

13:08 EDT 17 Sep 2019 | SCRIP

Dermatology-focused regenerative medicine firm Fibrocell has been reviewing strategic opportunities for more than a year; April’s FCX-007 license deal with...

      

Related Stories

 

Original Article: Deal Watch: Castle Creek Likes Partner Fibrocell Enough To Buy It

NEXT ARTICLE

More From BioPortfolio on "Deal Watch: Castle Creek Likes Partner Fibrocell Enough To Buy It"

Quick Search

Relevant Topics

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...